Related Experiment Video
Updated: Jun 24, 2026

Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens
Published on: December 17, 2019
Macrophage-Dependent Intercellular Crosstalk in Multiphenotypic Heart Failure With Preserved Ejection Fraction.
Yangyang Huang1,2, Lingyun Luo3,4, Xiantao Ma1,2
1Department of Geriatrics, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China.
Heart failure with preserved ejection fraction (HFpEF) involves complex inflammation and metabolic issues. Cardiac macrophages drive HFpEF progression, suggesting they are key therapeutic targets for this condition.
Area of Science:
- Cardiology
- Immunology
- Metabolic Syndrome
Background:
- Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome, not a single disease.
- Cardiac macrophages are key immune cells involved in HFpEF pathogenesis.
- HFpEF involves inflammation and metabolic dysregulation.
Purpose of the Study:
- To review the role of cardiac macrophages in HFpEF.
- To explore the heterogeneity of cardiac macrophages and HFpEF phenotypes.
- To synthesize evidence on how risk factors reprogram macrophages in HFpEF.
Main Methods:
- Literature review synthesizing preclinical and clinical evidence.
- Analysis of macrophage heterogeneity and phenotypic switching.
- Examination of macrophage interactions with other cardiac cells.
Main Results:
- Risk factors like aging and hypertension reprogram cardiac macrophages.
- Reprogrammed macrophages promote inflammation, fibrosis, and endothelial dysfunction.
- Macrophage-driven crosstalk exacerbates maladaptive cardiac remodeling.
Conclusions:
- Cardiac macrophages orchestrate a vicious cycle in HFpEF.
- Targeting specific macrophage subsets offers a potential therapeutic strategy for HFpEF.
- Addressing macrophage dysfunction is crucial for managing this heterogeneous syndrome.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Myocarditis I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chronic Inflammation: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
